24/7 Wall Street
05 Jan 2026, 15:33 UTC · 42w ago
Verdict
Headline takes no side. We score XOM +0.90 across five claims — strongly bullish.
+0.90strongly bullish
More positive than 97% of ticker scores this week
What the story claims
5 claims · scored −1 bearish … +1 bullish
AbbVie pays a $6.56 annual dividend against only $1.33 in diluted earnings per share, resulting in a 493% earnings payout ratio due to an 88.7% year-over-year earnings decline in Q3 2025 from the Humira patent cliff.
More negative than 98% of claims this week
DHS's dividend payments declined from $3.53 in 2023 to $3.23 in 2025, representing an 8.5% decrease over two years.
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
More negative than 92% of claims this week
Altria carries elevated risk with a 78% payout ratio and a negative book value of -$1.576, reflecting heavy debt from buybacks amid declining cigarette volumes and regulatory headwinds.
More negative than 88% of claims this week
Exxon Mobil demonstrates exceptional dividend safety, paying its $3.96 annual dividend from only 30% of its $55 billion operating cash flow, with $33.7 billion in net income providing substantial room for growth.
More positive than 64% of claims this week
Over 10 years, DHS gained 148% versus the S&P 500's 230%, significantly underperforming the broader market despite offering lower volatility and consistent income.
More negative than 80% of claims this week
Which stocks this story touches
More positive than 97% of ticker scores this week
Demonstrates exceptional dividend safety, a fortress balance sheet, and strong net income.
More negative than 83% of ticker scores this week
Carries elevated risk due to declining cigarette volumes, regulatory headwinds, and negative book value.
More positive than 77% of ticker scores this week
Recommended as a quality alternative with better focus on dividend consistency and growth.
More negative than 80% of ticker scores this week
Facing significant earnings declines and a high payout ratio due to the Humira patent loss.
More positive than 66% of ticker scores this week
The fund has delivered strong total returns and stability for retirees, despite a slight decline in monthly distributions.
More negative than 69% of ticker scores this week
Mentioned as part of a problematic tobacco exposure for ESG-conscious investors.
More positive than 54% of ticker scores this week
Mentioned positively for generating a high yield.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
The Motley Fool
16h ago
+46.7%
Price agrees with the score
$179.88 vs $122.65 close before publication (Jan 2) · not market-adjusted
XOM chart →
